Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.
Save up to 30% on print and eBooks.
Bioprinting
Techniques and Risks for Regenerative Medicine
1st Edition - February 17, 2017
Author: Maika G. Mitchell
Language: English
Paperback ISBN:9780128053690
9 7 8 - 0 - 1 2 - 8 0 5 3 6 9 - 0
eBook ISBN:9780128094037
9 7 8 - 0 - 1 2 - 8 0 9 4 0 3 - 7
Innovation is added value to a known process. Bioprinting: Techniques and Risks for Regenerative Medicine aims to stimulate a scientifically grounded, interdisciplinary, multiscal…Read more
Purchase options
LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code is needed.
Innovation is added value to a known process. Bioprinting: Techniques and Risks for Regenerative Medicine aims to stimulate a scientifically grounded, interdisciplinary, multiscale debate and exchange of ideas using the techniques described in the book. 3D printing and additive manufacturing evolved from within the field of Cell Biology will have the ability to recreate cells queried from large amounts of phenotypic and molecular data. Stem Cell biologists, biotechnologists and material engineers, as well as graduate students will greatly benefit from the practical knowledge and case examples provided throughout this book.
Shows the possible risk of rejection of 3D printed cells.
Contains bioprinting techniques in literature plus actual 3D files adapted and created by the author using several types of 3d printers
Provides information on how to convert an existing 3-D printer to bioprinter using currently available techniques
Describes the increased complexity of bioprinting compared to 3D- printing
Discussion on how 3D printing and additive manufacturing offers the opportunity to 3D print an entire organ, reducing the associated costs of this process when using cells as bioink
Life Science Researchers and Biomechanical, Biochemical, and Biomaterial Engineers. The techniques described help to advance discovery of new materials or instrumentations
Chapter 1. Biomanufacturing: The Definition and Evolution of a New Genre
Abstract
What Is 3D Printing?
References
Online Resources on Biomanufacturing
Chapter 2. Reproducing Cells Is Nothing New—A Historical Prospective
Abstract
Use in Research
2D and 3D Cell Culture Applications Leading to Bioprinting
References
Chapter 3. Bioprinting Versus 3D Printing
Abstract
3D Printers (and Types) I Personally Own and Use
Software
Micro 3D Heart 3D Print
iBox Nano Heart 3D Print
FlashForge Dreamer Heart 3D Print
The 3D History of Bioprinting
Just Like an Inkjet Printer, Sort Of
Steps to Personalized Medicine; Made-to-Order Human Organs
Conventional Steps Proposed for 3D Bioprinting Human Organs
Uses for 3D Organs
Further Reading
Chapter 4. Bioprinters in Use Today
Abstract
Inkjet-Based Bioprinting
Laser-Assisted Bioprinting
Microextrusion-Based Bioprinting
BioBots
References
Chapter 5. Materials for Use in Bioprinting
Abstract
Bioink Materials
3D Printing Biodegradable Polymers
Thermogels/Gel Formers
How Does It Work?
Thermpolymers for 3D Printing
Medical Implants
Biobots
Poloxamer 407
Gelatin Type A 300 Bloom
References
Chapter 6. CT Scans Function Like a CAD Design
Abstract
Get the Scan Data
Get the Scan Data Into Osirix
Clinical Image Data in 2D/3D View
Export of DICOM Image Scan as 3D Printable Model
Other Uses for DICOM Images
MicroDicom Shell Extension
Preparing for 3D Printing
References
Chapter 7. Additive Manufacturing and 3D Bioprinting for Pharmaceutical Testing
Abstract
Tissue Engineering
3D Scaffold Fabrication by Lithography and Printing Techniques
References
Chapter 8. Advances in Personalized Medicine: Bioprinted Tissues and Organs
Abstract
FDA Final Guidance on 3D Printing and Understanding the Specific Regulatory Challenges
Machine Parameters and Environmental Conditions
Material Controls
Additional Resources
References
No. of pages: 154
Language: English
Edition: 1
Published: February 17, 2017
Imprint: Academic Press
Paperback ISBN: 9780128053690
eBook ISBN: 9780128094037
MM
Maika G. Mitchell
The lead scientist and principle author in numerous studies involving tumor immunology, Dr. Mitchell has current teaching experience in anatomy and physiology, including recognition for contributions to research development, revenue-focused product development and management of high-tech operations. She is a contributor to the NCBI SNP database for pediatirc and urological cancers.
Dr. Mitchell has been a research scientist for well over 17 years in the biomedical field, most recently as Senior Director of Research & Development in Greater New York conducting flow cytometry and molecular-based assays in conjunction with bioinformatics.
Affiliations and expertise
ASCP, NSBE, AACC, CAP, NYSDOH, Lean Six Sigma Master Black Belt, MSKCC, CLC bio, The Science Advisory Board, BioConference Live!, Touch Oncology, PRIMR, and Lean In Community